- cafead Jan 28, 2022 at 10:12: AM
via Biogen will sell its equity stake in the biosimilars joint venture to Samsung Biologics for up to $2.3bn.
article source
article source
-
Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page
Biogen to sell stake in Samsung Bioepis JV for up to $2.3bn
- Thread starter cafead
- Start date
<
Similar threads